<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04590027</url>
  </required_header>
  <id_info>
    <org_study_id>621/2013BO1</org_study_id>
    <nct_id>NCT04590027</nct_id>
  </id_info>
  <brief_title>Caudal Block Versus Local Wound Infiltration for Inguinal Procedures</brief_title>
  <official_title>Caudal Block Versus Local Wound Infiltration for Inguinal Procedures in Young Children. A Prospective Observational Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single-centre observational study to analyse whether there is a difference in post-operative&#xD;
      pain scores and set up time when comparing caudal block with local wound infiltration&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Inguinal procedures in children are surgical frequently performed in an outpatient setting.&#xD;
      This study analyzed regional analgesia for inguinal procedures in toddlers comparing caudal&#xD;
      block with local wound infiltration and assessed post-operative pain scores as well as&#xD;
      process times.A number of documents were compiled to inform and record data: a standard&#xD;
      anaesthesia protocol, a documentation sheet for intraoperative recording, an information&#xD;
      leaflet for the parents and a documentation sheet for the post-operative course of 24 hours .&#xD;
&#xD;
      Caudal anaesthesia was performed after induction of anaesthesia. In patients getting wound&#xD;
      infiltration ropivacaine 0.375% 0.5 ml kg-1 was injected subcutaneously after closing of the&#xD;
      fascia transversalis.&#xD;
&#xD;
      Parents were informed about the study and invited to participate upon arriving on the&#xD;
      outpatient ward if the patient fulfilled the following inclusion criteria: scheduled for&#xD;
      elective inguinal procedure, age three to 72 months, no contraindication for either local or&#xD;
      caudal analgesia, no comorbidities. If parents agreed to participate, written informed&#xD;
      consent was obtained. Pain score and administration of analgesics, vomiting, interval until&#xD;
      micturition and interval until mobilization as well as sleep quality during the first&#xD;
      post-operative night were documented by the parents in the provided booklet.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 1, 2014</start_date>
  <completion_date type="Actual">January 30, 2020</completion_date>
  <primary_completion_date type="Actual">June 30, 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of Analgesia Quality Between the Two Groups</measure>
    <time_frame>Arrival on postoperative care unit (PCU), arrival ward, 1h, 2 h 3h, 4h, 5h, 6h, 12h. 24h,</time_frame>
    <description>Visual Analog Score (VAS) Minimum 0 (no pain) and Maximum 10 (worst pain) A two point difference of mean pain scores was defined as clinically meaningful to establish a superiority for one of the procedures of pain management</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Set up Time</measure>
    <time_frame>Time in minutes measured between start of induction of anesthesia to start of surgical incision</time_frame>
    <description>How much times goes by for induction of anesthesia in both groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rescue Medication</measure>
    <time_frame>24 hours</time_frame>
    <description>total number of analgesic doses across all participants</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurological Outcome</measure>
    <time_frame>24 hours</time_frame>
    <description>Time until first micturation an time to motor activity</description>
  </secondary_outcome>
  <enrollment type="Actual">86</enrollment>
  <condition>Anesthesia, Caudal</condition>
  <eligibility>
    <study_pop>
      <textblock>
        outpatient setting&#xD;
&#xD;
        paediatric inguinal procedures classifeind ASA 1 or 2 perfomed from the department of&#xD;
        paediatric surgery&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        -&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  no return of questionnaire&#xD;
&#xD;
          -  parents do not understand language&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>3 Months</minimum_age>
    <maximum_age>68 Months</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>August 2020</verification_date>
  <study_first_submitted>September 16, 2020</study_first_submitted>
  <study_first_submitted_qc>October 9, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 19, 2020</study_first_posted>
  <results_first_submitted>February 23, 2021</results_first_submitted>
  <results_first_submitted_qc>June 22, 2021</results_first_submitted_qc>
  <results_first_posted type="Actual">July 14, 2021</results_first_posted>
  <last_update_submitted>June 22, 2021</last_update_submitted>
  <last_update_submitted_qc>June 22, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 14, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>caudal block</keyword>
  <keyword>wound infiltration</keyword>
  <keyword>postoperative pain</keyword>
  <keyword>outpatient surgery</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>The clinical trial was conducted at the University Hospital of Tuebingen, Germany, where paediatric inguinal procedures in children classified as ASA I or ASA II ( American Society of Anesthesiologists Physical Status System) are performed in an outpatient setting. Recruitment period:Between February 2014 and June 2015,</recruitment_details>
      <pre_assignment_details>Causes for exclusion from the study No return of Questionaire (n=31) Not meeting criteria for anaesthesia (n=3)</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Caudal Block</title>
          <description>Caudal anaesthesia was performed after induction of anaesthesia. The puncture site was preoperatively anesthetized with Eutetic Mixture of Local Anaesthetics (EMLA®). The patient was then placed in a lateral decubitus position with left side down. An Epican® Paed 23G Tuohy needle was inserted into the epidural space using anatomical landmarks. After negative aspiration, a combination of a local anaesthetic (1 ml kg-1 ropivacaine 0,2%) and clonidine (2 μg kg-1) was applied.</description>
        </group>
        <group group_id="P2">
          <title>Local Infiltration (LI)</title>
          <description>In patients randomised to the Local Infiltration group (LI) ropivacaine 0.375% 0.5 ml kg-1 was injected subcutaneously after closing of the fascia transversalis.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="47"/>
                <participants group_id="P2" count="39"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="30"/>
                <participants group_id="P2" count="22"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="17"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Lost to Follow-up</title>
              <participants_list>
                <participants group_id="P1" count="17"/>
                <participants group_id="P2" count="14"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="3"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Caudal Block (CB)</title>
          <description>Caudal Block (CB)&#xD;
pain management&#xD;
1 ml kg-1 ropivacaine and clonidine 2 ug kg-1</description>
        </group>
        <group group_id="B2">
          <title>Local Infiltration (LI)</title>
          <description>Local Infiltration (LI) pain management 0.375% 0.5 ml kg-1 ropivacaine injected subcutaneously</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="47"/>
            <count group_id="B2" value="39"/>
            <count group_id="B3" value="86"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <population>The random sample was 52 patients. 34 patients were excluded.</population>
          <units>month</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="30"/>
                    <count group_id="B2" value="22"/>
                    <count group_id="B3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="21" spread="14.7"/>
                    <measurement group_id="B2" value="30" spread="18.8"/>
                    <measurement group_id="B3" value="25.5" spread="16.75"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="47"/>
                    <count group_id="B2" value="39"/>
                    <count group_id="B3" value="86"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="44"/>
                    <measurement group_id="B2" value="35"/>
                    <measurement group_id="B3" value="79"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Germany</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="47"/>
                    <count group_id="B2" value="39"/>
                    <count group_id="B3" value="86"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="47"/>
                    <measurement group_id="B2" value="39"/>
                    <measurement group_id="B3" value="86"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Weight of Children</title>
          <description>weight measured in kg</description>
          <population>Thirty-one patients had to be excluded from the analysis because the parents did not return the questionnaire. Another three patients were excluded because the specified anaesthesia protocol was not followed.</population>
          <units>kilogram</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="30"/>
                    <count group_id="B2" value="22"/>
                    <count group_id="B3" value="52"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10" lower_limit="6.5" upper_limit="18"/>
                    <measurement group_id="B2" value="12" lower_limit="8.2" upper_limit="24"/>
                    <measurement group_id="B3" value="11" lower_limit="6.5" upper_limit="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Comparison of Analgesia Quality Between the Two Groups</title>
        <description>Visual Analog Score (VAS) Minimum 0 (no pain) and Maximum 10 (worst pain) A two point difference of mean pain scores was defined as clinically meaningful to establish a superiority for one of the procedures of pain management</description>
        <time_frame>Arrival on postoperative care unit (PCU), arrival ward, 1h, 2 h 3h, 4h, 5h, 6h, 12h. 24h,</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Caudal Block</title>
            <description>Ropivacaine 0,2 % 1 ml kg-1 and clonidine 2 μg kg-1</description>
          </group>
          <group group_id="O2">
            <title>Local Infiltration</title>
            <description>Ropivacaine 0.375% 0.5 ml kg-1 was injected subcutaneously</description>
          </group>
        </group_list>
        <measure>
          <title>Comparison of Analgesia Quality Between the Two Groups</title>
          <description>Visual Analog Score (VAS) Minimum 0 (no pain) and Maximum 10 (worst pain) A two point difference of mean pain scores was defined as clinically meaningful to establish a superiority for one of the procedures of pain management</description>
          <units>score on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Error</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Arrival PCU</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.86" spread="0.43"/>
                    <measurement group_id="O2" value="3.09" spread="0.51"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Arrival ward</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.83" spread="0.5"/>
                    <measurement group_id="O2" value="2.95" spread="0.58"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.36" spread="0.31"/>
                    <measurement group_id="O2" value="2.13" spread="0.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.3" spread="0.33"/>
                    <measurement group_id="O2" value="1.68" spread="0.39"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.43" spread="0.31"/>
                    <measurement group_id="O2" value="1.54" spread="0.36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2.0" spread="0.34"/>
                    <measurement group_id="O2" value="0.86" spread="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>5h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.76" spread="0.34"/>
                    <measurement group_id="O2" value="0.77" spread="0.40"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>6h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.5" spread="0.28"/>
                    <measurement group_id="O2" value="1.00" spread="0.33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>12h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1.56" spread="0.35"/>
                    <measurement group_id="O2" value="1.31" spread="0.41"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>24 h</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="0.56" spread="0.22"/>
                    <measurement group_id="O2" value="0.68" spread="0.26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Non-Inferiority</non_inferiority_type>
            <non_inferiority_desc>power calculation was not recorded Definition of non inferiority: two point difference of pain score at the measurement times</non_inferiority_desc>
            <p_value>&lt;0.05</p_value>
            <method>ANCOVA</method>
            <method_desc>To rule out confounders due to an age difference, the ANCOVA test was applied to compare the differences in pain scores age-unrelatedly.</method_desc>
            <other_analysis_desc>Fisher Yates Test to compare the requirement of resue medication</other_analysis_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Set up Time</title>
        <description>How much times goes by for induction of anesthesia in both groups</description>
        <time_frame>Time in minutes measured between start of induction of anesthesia to start of surgical incision</time_frame>
        <population>to analyze which procedure is less time consuming</population>
        <group_list>
          <group group_id="O1">
            <title>Caudal Block</title>
            <description>Ropivacaine 0,2% 1ml kg-1 and clonidine 2µg kg-1</description>
          </group>
          <group group_id="O2">
            <title>Local Infiltration</title>
            <description>Ropivacaine 0.375% 0.5 ml kg-1 subcutaneously</description>
          </group>
        </group_list>
        <measure>
          <title>Set up Time</title>
          <description>How much times goes by for induction of anesthesia in both groups</description>
          <population>to analyze which procedure is less time consuming</population>
          <units>minutes</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="22.5" lower_limit="16" upper_limit="46"/>
                    <measurement group_id="O2" value="17" lower_limit="10" upper_limit="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority</non_inferiority_type>
            <p_value>&lt;0.05</p_value>
            <method>Chi-squared</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Rescue Medication</title>
        <description>total number of analgesic doses across all participants</description>
        <time_frame>24 hours</time_frame>
        <population>The need for rescue medicine is an indirect parameter for the effectiveness of the analgesic procedure.</population>
        <group_list>
          <group group_id="O1">
            <title>Caudal Block</title>
            <description>ropivacaine 0,2% 1 ml kg-1 and clonidine 2 μg kg-1</description>
          </group>
          <group group_id="O2">
            <title>Local Infiltration</title>
            <description>Ropivacaine 0.375% 0.5 ml kg-1</description>
          </group>
        </group_list>
        <measure>
          <title>Rescue Medication</title>
          <description>total number of analgesic doses across all participants</description>
          <population>The need for rescue medicine is an indirect parameter for the effectiveness of the analgesic procedure.</population>
          <units>total number analgesic dosis</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="30"/>
                <count group_id="O2" value="22"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="58"/>
                    <measurement group_id="O2" value="31"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Neurological Outcome</title>
        <description>Time until first micturation an time to motor activity</description>
        <time_frame>24 hours</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>0-24 h postoperatively</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Caudal Block</title>
          <description>Caudal anaesthesia was performed after induction of anaesthesia. The puncture site was preoperatively anesthetized with EMLA®. The patient was then placed in a lateral decubitus position with left side down. An Epican® Paed 23G Tuohy needle was inserted into the epidural space using anatomical landmarks. After negative aspiration, a combination of a local anaesthetic (1 ml kg-1 ropivacaine 0,2%) and clonidine (2 μg kg-1) was applied.</description>
        </group>
        <group group_id="E2">
          <title>Local Infiltration</title>
          <description>In patients randomised to the LI group ropivacaine 0.375% 0.5 ml kg-1 was injected subcutaneously after closing of the fascia transversalis.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="30"/>
                <counts group_id="E2" subjects_affected="3" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>vomiting</sub_title>
                <description>vomiting</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="30"/>
                <counts group_id="E2" events="3" subjects_affected="3" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>delayed micturation</sub_title>
                <counts group_id="E1" events="0" subjects_affected="0" subjects_at_risk="30"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="22"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Since postoperative pain and emergence delirium might overlap within the first half hour after the procedure, a paediatric anaesthesia emergence delirium scale might have been useful.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Dr. Barbara Schlisio</name_or_title>
      <organization>University of Tuebingen, Department of Anaesthesiology and Intensive Care Medicine</organization>
      <phone>+4970712985535</phone>
      <email>barbara.schlisio@med.uni-tuebingen.de</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

